These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 2332470)
1. Microculture assay for isolation of human immunodeficiency virus type 1 and for titration of infected peripheral blood mononuclear cells. Dimitrov DH; Melnick JL; Hollinger FB J Clin Microbiol; 1990 Apr; 28(4):734-7. PubMed ID: 2332470 [TBL] [Abstract][Full Text] [Related]
2. Sensitive microculture method for isolation of human immunodeficiency virus type 1 from blood leukocytes. Erice A; Sannerud KJ; Leske VL; Aeppli D; Balfour HH J Clin Microbiol; 1992 Feb; 30(2):444-8. PubMed ID: 1537914 [TBL] [Abstract][Full Text] [Related]
3. Expression of human immunodeficiency virus (HIV) in naturally infected peripheral blood mononuclear cells: comparison of a standard co-culture technique with a newly developed microculture method. Eberlein B; Baur A; Neundorfer M; Jahn G Virus Res; 1991 May; 19(2-3):153-61. PubMed ID: 1909827 [TBL] [Abstract][Full Text] [Related]
4. Recovery of human immunodeficiency virus from asymptomatic prostitutes from Tamil Nadu. Seth P; Sharma UK Indian J Med Res; 1991 Sep; 93():277-9. PubMed ID: 1778612 [TBL] [Abstract][Full Text] [Related]
5. Effective use of frozen donor peripheral blood mononuclear cells for human immunodeficiency virus type 1 isolation from vertically infected pediatric patients. Paul MO; Tetali S; Pahwa S J Clin Microbiol; 1994 May; 32(5):1379-82. PubMed ID: 8051275 [TBL] [Abstract][Full Text] [Related]
7. Allogeneic leukocytes but not therapeutic blood elements induce reactivation and dissemination of latent human immunodeficiency virus type 1 infection: implications for transfusion support of infected patients. Busch MP; Lee TH; Heitman J Blood; 1992 Oct; 80(8):2128-35. PubMed ID: 1391964 [TBL] [Abstract][Full Text] [Related]
8. High titers of cytopathic virus in plasma of patients with symptomatic primary HIV-1 infection. Clark SJ; Saag MS; Decker WD; Campbell-Hill S; Roberson JL; Veldkamp PJ; Kappes JC; Hahn BH; Shaw GM N Engl J Med; 1991 Apr; 324(14):954-60. PubMed ID: 1900576 [TBL] [Abstract][Full Text] [Related]
9. Isolation and quantification of HIV from lymph nodes. Tamalet C Methods Mol Biol; 2005; 304():87-94. PubMed ID: 16061968 [TBL] [Abstract][Full Text] [Related]
10. Standardized peripheral blood mononuclear cell culture assay for determination of drug susceptibilities of clinical human immunodeficiency virus type 1 isolates. The RV-43 Study Group, the AIDS Clinical Trials Group Virology Committee Resistance Working Group. Japour AJ; Mayers DL; Johnson VA; Kuritzkes DR; Beckett LA; Arduino JM; Lane J; Black RJ; Reichelderfer PS; D'Aquila RT Antimicrob Agents Chemother; 1993 May; 37(5):1095-101. PubMed ID: 8517697 [TBL] [Abstract][Full Text] [Related]
11. A semiquantitative microassay for measurement of relative number of blood mononuclear cells infected with human immunodeficiency virus. Gupta P; Enrico A; Armstrong J; Doerr M; Ho M; Rinaldo C AIDS Res Hum Retroviruses; 1990 Oct; 6(10):1193-6. PubMed ID: 2252638 [TBL] [Abstract][Full Text] [Related]
12. Similar replication capacities of primary human immunodeficiency virus type 1 isolates derived from a wide range of clinical sources. Lu W; Andrieu JM J Virol; 1992 Jan; 66(1):334-40. PubMed ID: 1727492 [TBL] [Abstract][Full Text] [Related]
13. Influence of exogenous interleukin-2 concentration on the isolation of human immunodeficiency virus. Zöllner B; Feucht HH; Hamann A; Laufs R Microbiol Immunol; 1995; 39(2):117-21. PubMed ID: 7783684 [TBL] [Abstract][Full Text] [Related]
14. Antibody-mediated neutralization of primary isolates of human immunodeficiency virus type 1 in peripheral blood mononuclear cells is not affected by the initial activation state of the cells. Zhou JY; Montefiori DC J Virol; 1997 Mar; 71(3):2512-7. PubMed ID: 9032392 [TBL] [Abstract][Full Text] [Related]
15. Human immunodeficiency virus type 1 mRNA expression in peripheral blood cells predicts disease progression independently of the numbers of CD4+ lymphocytes. Saksela K; Stevens C; Rubinstein P; Baltimore D Proc Natl Acad Sci U S A; 1994 Feb; 91(3):1104-8. PubMed ID: 7905630 [TBL] [Abstract][Full Text] [Related]
16. In vitro immunologic and virologic effects of interleukin 15 on peripheral blood mononuclear cells from normal donors and human immunodeficiency virus type 1-infected patients. Lucey DR; Pinto LA; Bethke FR; Rusnak J; Melcher GP; Hashemi FN; Landay AL; Kessler HA; Paxton RJ; Grabstein K; Shearer GM Clin Diagn Lab Immunol; 1997 Jan; 4(1):43-8. PubMed ID: 9008279 [TBL] [Abstract][Full Text] [Related]
17. Plasma viremia in human immunodeficiency virus infection. Coombs RW; Collier AC; Allain JP; Nikora B; Leuther M; Gjerset GF; Corey L N Engl J Med; 1989 Dec; 321(24):1626-31. PubMed ID: 2511447 [TBL] [Abstract][Full Text] [Related]
18. Isolation of HIV-1 from plasma of infected individuals: an analysis of experimental conditions affecting successful virus propagation. Dewar RL; Sarmiento MD; Lawton ES; Clark HM; Kennedy PE; Shah A; Baseler M; Metcalf JA; Lane HC; Salzman NP J Acquir Immune Defic Syndr (1988); 1992; 5(8):822-8. PubMed ID: 1355557 [TBL] [Abstract][Full Text] [Related]
19. Assessment of human immunodeficiency virus expression in cocultures of peripheral blood mononuclear cells from healthy seropositive subjects. Ulrich PP; Busch MP; el-Beik T; Shiota J; Vennari J; Shriver K; Vyas GN J Med Virol; 1988 May; 25(1):1-10. PubMed ID: 3411308 [TBL] [Abstract][Full Text] [Related]
20. Efficient and reproducible new semimicromethod for the detection and titration of HIV in human plasma. Andreoni M; Sarmati L; Parisi SG; Ercoli L; Rocchi G J Med Virol; 1992 Nov; 38(3):207-13. PubMed ID: 1363119 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]